MX358730B - Metodos para predecir y monitorear cicatrizacion de la mucosa. - Google Patents
Metodos para predecir y monitorear cicatrizacion de la mucosa.Info
- Publication number
- MX358730B MX358730B MX2015004272A MX2015004272A MX358730B MX 358730 B MX358730 B MX 358730B MX 2015004272 A MX2015004272 A MX 2015004272A MX 2015004272 A MX2015004272 A MX 2015004272A MX 358730 B MX358730 B MX 358730B
- Authority
- MX
- Mexico
- Prior art keywords
- mucosal healing
- predicting
- monitoring
- methods
- present
- Prior art date
Links
- 230000035876 healing Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000012544 monitoring process Methods 0.000 title abstract 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261710491P | 2012-10-05 | 2012-10-05 | |
| US201361824959P | 2013-05-17 | 2013-05-17 | |
| PCT/IB2013/059077 WO2014054013A1 (en) | 2012-10-05 | 2013-10-02 | Methods for predicting and monitoring mucosal healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015004272A MX2015004272A (es) | 2015-08-14 |
| MX358730B true MX358730B (es) | 2018-09-03 |
Family
ID=49447587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015004272A MX358730B (es) | 2012-10-05 | 2013-10-02 | Metodos para predecir y monitorear cicatrizacion de la mucosa. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150355195A1 (enExample) |
| EP (3) | EP3217179B9 (enExample) |
| JP (1) | JP2015532425A (enExample) |
| CN (1) | CN104838270A (enExample) |
| AU (2) | AU2013326070A1 (enExample) |
| CA (1) | CA2887035A1 (enExample) |
| ES (2) | ES2638971T3 (enExample) |
| HK (1) | HK1213051A1 (enExample) |
| MX (1) | MX358730B (enExample) |
| SG (1) | SG11201502646RA (enExample) |
| WO (1) | WO2014054013A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012253422B2 (en) | 2011-05-10 | 2015-08-13 | Société des Produits Nestlé S.A. | Methods of disease activity profiling for personalized therapy management |
| EP3210027B1 (en) * | 2014-10-20 | 2019-04-17 | Nestec S.A. | Methods for predicting clinical outcomes in subjects afflicted with ulcerative colitis |
| WO2016066174A1 (en) | 2014-10-29 | 2016-05-06 | Glycom A/S | Synthetic composition and method for promoting mucosal healing |
| GB201501612D0 (en) * | 2015-01-30 | 2015-03-18 | Univ Birmingham | Assay |
| GB201611738D0 (en) | 2016-07-05 | 2016-08-17 | Cambridge Entpr Ltd | Biomarkers for inflammatory bowel disease |
| CN111094984A (zh) | 2017-05-31 | 2020-05-01 | 普罗米修斯生物科学公司 | 克罗恩氏病患者的粘膜愈合评估方法 |
| CN110646620A (zh) * | 2019-09-29 | 2020-01-03 | 湖北新纵科病毒疾病工程技术有限公司 | 一种同时检测四项炎症标志物的方法及其试剂盒 |
| CN111477325A (zh) * | 2020-04-09 | 2020-07-31 | 赣南师范大学 | 基于粒子群优化算法对引发肠道溃疡疾病进行鉴别的方法 |
| CN120600283A (zh) * | 2025-05-29 | 2025-09-05 | 北京大学第三医院（北京大学第三临床医学院） | 一种基于临床知识图谱的中医生殖内分泌疾病诊断辅助系统 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0615129T3 (da) | 1993-03-10 | 2000-08-07 | Cedars Sinai Medical Center | Fremgangsmåder til selektiv påvisning af perinukleært anti-neutrophilt cytoplasmatisk antistof fra ulcerativ colitis eller |
| US5830675A (en) | 1993-03-10 | 1998-11-03 | Cedars-Sinai Medical Center | Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis |
| US6218129B1 (en) | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| AU2001253746A1 (en) * | 2000-04-20 | 2001-11-07 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Inducible plasmid vector encoding tgf-beta and uses thereof |
| US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
| AU2002365279B2 (en) | 2001-12-17 | 2009-08-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| US20040197304A1 (en) * | 2003-04-01 | 2004-10-07 | The Procter & Gamble Company And Alimentary Health, Ltd. | Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| EP1687447A4 (en) | 2003-11-03 | 2008-04-02 | Univ Duke | METHOD FOR IDENTIFYING INDIVIDUALS IN THE HAZARD OF PERIOPERATIVE BLOODING, A KIDNEY PROBLEM OR A STROKE |
| US20060019410A1 (en) | 2004-07-21 | 2006-01-26 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| US7868139B2 (en) | 2006-01-24 | 2011-01-11 | Uab Research Foundation | Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases |
| RU2442171C2 (ru) | 2006-09-21 | 2012-02-10 | Промитьюс Лабораториз Инк. | Чипы на основе антител для определения множественных трансдукторов сигналов в редких циркулирующих клетках |
| AU2008276251B2 (en) | 2007-07-13 | 2014-04-24 | Nestec S.A. | Drug selection for lung cancer therapy using antibody-based arrays |
| EP2602623B1 (en) | 2008-02-25 | 2015-09-16 | Nestec S.A. | Mehtod for the detection of intracellular truncated receptors |
| CN107041948A (zh) * | 2009-01-21 | 2017-08-15 | 北京三有利科技发展有限公司 | 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用 |
| EP2430443B1 (en) | 2009-05-14 | 2018-06-27 | Pierian Holdings, Inc. | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
| EP2454598B1 (en) | 2009-07-15 | 2017-03-22 | DiaTech Holdings, Inc. | Drug selection for gastric cancer therapy using antibody-based arrays |
| CA2777934A1 (en) | 2009-10-20 | 2011-04-28 | Prometheus Laboratories Inc. | Proximity-mediated assays for detecting oncogenic fusion proteins |
| NZ599456A (en) | 2009-10-26 | 2014-06-27 | Nestec Sa | Assays for the detection of anti-tnf drugs and autoantibodies |
| AU2010324735A1 (en) * | 2009-11-25 | 2012-07-12 | Nestec S.A. | Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| MX2012014096A (es) * | 2010-06-04 | 2013-04-19 | Nestec Sa | Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria. |
| AU2011317149B2 (en) | 2010-10-18 | 2015-05-07 | Société des Produits Nestlé S.A. | Methods for determining anti-drug antibody isotypes |
| SG10201510086VA (en) | 2010-12-23 | 2016-01-28 | Nestec Sa | Drug selection for malignant cancer therapy using antibody-based arrays |
| SG192770A1 (en) | 2011-02-17 | 2013-09-30 | Nestec Sa | Assays for detecting autoantibodies to anti-tnfalpha drugs |
| EP2908132B8 (en) | 2011-03-02 | 2019-06-12 | Nestec S.A. | Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures |
| SG10201605516YA (en) | 2011-07-06 | 2016-08-30 | Nestec Sa | Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha |
| KR101851425B1 (ko) | 2011-09-02 | 2018-04-23 | 네스텍 소시에테아노님 | 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링 |
-
2013
- 2013-10-02 ES ES13779638.9T patent/ES2638971T3/es active Active
- 2013-10-02 ES ES17167637T patent/ES2771127T3/es active Active
- 2013-10-02 CA CA2887035A patent/CA2887035A1/en not_active Abandoned
- 2013-10-02 WO PCT/IB2013/059077 patent/WO2014054013A1/en not_active Ceased
- 2013-10-02 EP EP17167637.2A patent/EP3217179B9/en active Active
- 2013-10-02 CN CN201380063566.2A patent/CN104838270A/zh active Pending
- 2013-10-02 EP EP19212960.9A patent/EP3640645A1/en not_active Withdrawn
- 2013-10-02 MX MX2015004272A patent/MX358730B/es active IP Right Grant
- 2013-10-02 JP JP2015535153A patent/JP2015532425A/ja active Pending
- 2013-10-02 AU AU2013326070A patent/AU2013326070A1/en not_active Abandoned
- 2013-10-02 SG SG11201502646RA patent/SG11201502646RA/en unknown
- 2013-10-02 EP EP13779638.9A patent/EP2904405B1/en not_active Not-in-force
- 2013-10-02 HK HK16100852.9A patent/HK1213051A1/zh unknown
-
2015
- 2015-04-03 US US14/678,455 patent/US20150355195A1/en not_active Abandoned
-
2019
- 2019-06-19 AU AU2019204276A patent/AU2019204276A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2904405A1 (en) | 2015-08-12 |
| US20150355195A1 (en) | 2015-12-10 |
| EP3640645A1 (en) | 2020-04-22 |
| EP3217179B9 (en) | 2020-06-10 |
| SG11201502646RA (en) | 2015-05-28 |
| EP3217179A1 (en) | 2017-09-13 |
| EP2904405B1 (en) | 2017-05-31 |
| ES2638971T3 (es) | 2017-10-24 |
| ES2771127T3 (es) | 2020-07-06 |
| AU2019204276A1 (en) | 2019-07-04 |
| AU2013326070A1 (en) | 2015-04-23 |
| WO2014054013A1 (en) | 2014-04-10 |
| CN104838270A (zh) | 2015-08-12 |
| HK1213051A1 (zh) | 2016-06-24 |
| MX2015004272A (es) | 2015-08-14 |
| JP2015532425A (ja) | 2015-11-09 |
| EP3217179B1 (en) | 2020-01-08 |
| CA2887035A1 (en) | 2014-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX358730B (es) | Metodos para predecir y monitorear cicatrizacion de la mucosa. | |
| EP3065777A4 (en) | Methods of use for il-22 in the treatment of gastrointestinal graft vs. host disease | |
| PH12013500065A1 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
| MX2013000917A (es) | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. | |
| IL235771A0 (en) | Respirometer system and data analysis methods | |
| MX2013008390A (es) | Preparacion de estructuras de metal-triazolato. | |
| EA201691314A1 (ru) | Терапевтические способы и композиции | |
| UY4153Q (es) | Batería | |
| UY34582A (es) | Anticuerpos anti-cxcr3 | |
| EP3058097A4 (en) | Sense-antisense gene pairs for patient stratification, prognosis, and therapeutic biomarkers identification | |
| MX365403B (es) | Peptidos y metodos para usarlos. | |
| WO2012166626A8 (en) | Reagents and methods for treating dental disease | |
| UY4281Q (es) | Juguera | |
| HK1209035A1 (en) | Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta | |
| UY4223Q (es) | Banco | |
| MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
| MX2021006626A (es) | Marcadores geneticos para predecir la reactividad a terapia con agente que eleva la lipoproteina de alta densidad (hdl) o que imita la lipoproteina de alta densidad (hdl). | |
| EP2831101A4 (en) | LOADED NUTRIENT FRAGMENTS, PROTEINS AND METHOD | |
| BR112013024363A2 (pt) | método, e aparelho | |
| NZ712023A (en) | Caix stratification based cancer treatment | |
| GB201102108D0 (en) | Diagnostic method | |
| UY4152Q (es) | Batería | |
| UY4243Q (es) | Banco | |
| MX358340B (es) | Extractos de tomillo silvestre y su uso. | |
| MX351765B (es) | Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |